NVAX Shares Outstanding History
Below is a table of the NVAX shares outstanding history going back to 3/11/2010:

Date NVAX Shares Outstanding
3/11/20105.01M
4/30/20105.02M
7/31/20105.37M
10/31/20105.56M
3/22/20115.58M
4/30/20115.61M
7/31/20115.76M
10/31/20115.75M
3/8/20126.08M
4/30/20126.11M
7/31/20126.68M
10/31/20127.40M
3/4/20137.40M
4/30/20137.62M
7/30/20137.64M
10/31/201310.43M
3/6/201410.45M
4/30/201410.46M
7/31/201411.92M
10/31/201411.92M
2/23/201511.97M
4/30/201513.40M
7/31/201513.48M
10/31/201513.49M
2/24/201613.52M
4/30/201613.54M
7/31/201613.56M
10/31/201613.56M
2/23/201713.60M
4/30/201714.13M
7/31/201714.71M
10/31/201715.68M
3/9/201817.19M
4/30/201819.08M
8/3/201819.13M
10/31/201819.14M
3/12/201922.07M
4/25/201923.47M
5/10/201923.47M
7/31/201923.92M
9/16/2019285.64M
10/31/201926.58M
3/6/202051.53M
4/17/202057.94M
4/30/202057.96M
7/31/202061.28M
10/31/202063.66M
2/24/202173.86M
4/27/202174.09M
4/30/202174.09M
7/31/202174.48M
10/31/202175.61M

Also see: NVAX Market Cap History
NVAX YTD Return
NVAX Historical Shares Outstanding:
+26.23% CAGR
NVAX Historical Shares Outstanding: +26.23% CAGR

Mouse over chart for data details
3/11/2010 ...10/31/2021
Novavax is a biotechnology company promoting improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, (NVX-CoV2373) and its nanoparticle seasonal quadrivalent influenza vaccine candidate (NanoFlu), are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. Co.'s technology may be used to target a variety of infectious diseases. Co.'s technology is paired with its proprietary immune stimulating adjuvants, developed at Novavax AB, its wholly owned Swedish subsidiary. We show 52 historical shares outstanding datapoints in our coverage of NVAX's shares outstanding history.

Understanding the changing numbers of NVAX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NVAX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NVAX by allowing them to research NVAX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree NVAX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Novavax (NVAX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

NVIV Shares Outstanding History
NVNO Shares Outstanding History
NVO Shares Outstanding History
NVOS Shares Outstanding History
NVRO Shares Outstanding History
NVST Shares Outstanding History
NVTA Shares Outstanding History
NVTR Shares Outstanding History
NVUS Shares Outstanding History
NXTC Shares Outstanding History
More Healthcare companies »

 

NVAX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.